167 related articles for article (PubMed ID: 18456253)
21. Mechanism of action of memantine.
Johnson JW; Kotermanski SE
Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
[TBL] [Abstract][Full Text] [Related]
22. Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg2+.
Wollmuth LP; Kuner T; Sakmann B
J Physiol; 1998 Jan; 506 ( Pt 1)(Pt 1):13-32. PubMed ID: 9481670
[TBL] [Abstract][Full Text] [Related]
23. NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G.
Ragnarsson L; Yasuda T; Lewis RJ; Dodd PR; Adams DJ
J Neurochem; 2006 Jan; 96(1):283-91. PubMed ID: 16336218
[TBL] [Abstract][Full Text] [Related]
24. NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterization.
Danysz W; Parsons CG; Quack G
Amino Acids; 2000; 19(1):167-72. PubMed ID: 11026485
[TBL] [Abstract][Full Text] [Related]
25. Stimulatory and inhibitory properties of aminoglycoside antibiotics at N-methyl-D-aspartate receptors.
Masuko T; Kuno T; Kashiwagi K; Kusama T; Williams K; Igarashi K
J Pharmacol Exp Ther; 1999 Sep; 290(3):1026-33. PubMed ID: 10454474
[TBL] [Abstract][Full Text] [Related]
26. Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta.
Giustizieri M; Cucchiaroni ML; Guatteo E; Bernardi G; Mercuri NB; Berretta N
J Pharmacol Exp Ther; 2007 Aug; 322(2):721-9. PubMed ID: 17496164
[TBL] [Abstract][Full Text] [Related]
27. Design of antagonists for NMDA and AMPA receptors.
Bolshakov KV; Kim KH; Potapjeva NN; Gmiro VE; Tikhonov DB; Usherwood PN; Mellor IR; Magazanik LG
Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
[TBL] [Abstract][Full Text] [Related]
28. Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors.
Liu YW; Li CY; Luo JL; Li WM; Fu HJ; Lao YZ; Liu LJ; Pang YP; Chang DC; Li ZW; Peoples RW; Ai YX; Han YF
Biochem Biophys Res Commun; 2008 May; 369(4):1007-11. PubMed ID: 18328812
[TBL] [Abstract][Full Text] [Related]
29. Potencies and unblocking kinetic properties of antagonists at recombinant human NMDA receptors in a Xenopus oocytes model.
Heusler P; Tourette A; Cussac D
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):509-16. PubMed ID: 25604077
[TBL] [Abstract][Full Text] [Related]
30. Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine.
Hare WA; Wheeler L
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2940-8. PubMed ID: 19136701
[TBL] [Abstract][Full Text] [Related]
31. Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels.
Askalany AR; Yamakura T; Petrenko AB; Kohno T; Sakimura K; Baba H
Neurosci Res; 2005 Aug; 52(4):387-92. PubMed ID: 15982768
[TBL] [Abstract][Full Text] [Related]
32. Intracellular Mg2+ interacts with structural determinants of the narrow constriction contributed by the NR1-subunit in the NMDA receptor channel.
Wollmuth LP; Kuner T; Sakmann B
J Physiol; 1998 Jan; 506 ( Pt 1)(Pt 1):33-52. PubMed ID: 9481671
[TBL] [Abstract][Full Text] [Related]
33. Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-aspartate receptor occupation and do not impair learning in rats.
Morè L; Gravius A; Nagel J; Valastro B; Greco S; Danysz W
Behav Pharmacol; 2008 Oct; 19(7):724-34. PubMed ID: 18797249
[TBL] [Abstract][Full Text] [Related]
34. Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.
Parsons CG; Danysz W; Bartmann A; Spielmanns P; Frankiewicz T; Hesselink M; Eilbacher B; Quack G
Neuropharmacology; 1999 Jan; 38(1):85-108. PubMed ID: 10193901
[TBL] [Abstract][Full Text] [Related]
35. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.
Lipton SA
Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917
[TBL] [Abstract][Full Text] [Related]
36. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
Kiss L; Cheng G; Bednar B; Bednar RA; Bennett PB; Kane SA; McIntyre CJ; McCauley JA; Koblan KS
Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
[TBL] [Abstract][Full Text] [Related]
37. Trapping channel block of NMDA-activated responses by amantadine and memantine.
Blanpied TA; Boeckman FA; Aizenman E; Johnson JW
J Neurophysiol; 1997 Jan; 77(1):309-23. PubMed ID: 9120573
[TBL] [Abstract][Full Text] [Related]
38. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.
Avenet P; Léonardon J; Besnard F; Graham D; Depoortere H; Scatton B
Neurosci Lett; 1997 Feb; 223(2):133-6. PubMed ID: 9089691
[TBL] [Abstract][Full Text] [Related]
39. Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARs.
Otton HJ; Lawson McLean A; Pannozzo MA; Davies CH; Wyllie DJ
Neuropharmacology; 2011; 60(2-3):388-96. PubMed ID: 20955720
[TBL] [Abstract][Full Text] [Related]
40. Patch clamp combined with voltage/concentration clamp to determine the kinetics and voltage dependency of N-methyl-D-aspartate (NMDA) receptor open channel blockers.
Parsons CG; Gilling KE
Methods Mol Biol; 2014; 1183():43-63. PubMed ID: 25023301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
